Beyond GLP-1. Unlock Novel GPCR Targets. Shape the Future of Drug Discovery.

Finding the Next Blockbuster GPCR-Targeted Therapeutic

Supercharging Discovery with Novel Technologies to Deconvolute MOAs, Elucidate Target Biology & Accelerate GPCR Drug Design

The GPCR field is entering its next phase of innovation. As biopharma looks beyond GLP-1 therapeutics for the next breakthrough opportunity, advances in AI-enabled drug discovery, GPCR structural biology, cryo-EM, structure-guided drug design, next-generation screening technologies, and GPCR signaling biology are transforming how researchers discover, validate, and drug novel GPCR targets. Yet critical challenges remain, from de-risking orphan GPCRs and advancing GPCR target validation to predicting functional activity and translating complex receptor biology into differentiated medicines.
The 6th GPCR-Targeted Drug Discovery Summit is the industry's only dedicated meeting focused exclusively on the future of GPCR drug discovery, bringing together leaders advancing next-generation GPCR therapeutics across targets, modalities, and therapeutic areas. Join experts from Eli Lilly, Pfizer, Roche, Recursion Pharmaceuticals, Alphamol, LEMBAS, Kainova Therapeutics, Duke University, University of Miami, and more to benchmark the latest advances in AI for GPCR drug discovery, orphan GPCR drug discovery, GPCR signaling, target validation, structure-based drug design, and emerging therapeutic modalities including antibodies, peptides, biologics, and ADCs.
Whether you're searching for the next target beyond GLP-1, exploring emerging GPCR targets, evaluating novel therapeutic modalities, or accelerating your pipeline through GPCR-targeted drug discovery, join 80+ industry and academic experts shaping the next GPCR success story and defining the future of drug discovery.

When you are in the business of developing drugs it is important to know what is going on right now and where the future might lie. The GPCR summit is the right place for that.

Benjamin Pelcman, Scientific Advisor, Atrogi

Atrogi Logo

The intimate scale of this meeting creates an excellent opportunity for valuable discussion and networking.

David O'Connell, Founder, SelekTx Precision Biologics

SelekTx Precision Biologics Logo

An excellent opportunity for industry partners to learn about cutting-edge science that can impact their discovery pipelines and foster connections with academic partners.

Sivaraj Sivaramakrishnan, Professor, University of Minnesota

University of Minnesota logo

Attending Companies Include

Eli Lilly
Confo Therapeutics
Kainova Therapeutics
DrGPCR Logo
Pfizer Logo
Roche Logo
Alkermes Logo
Biagon Inc. Logo

Explore the Full Event Guide

  • Explore the complete 2027 agenda, featuring a dedicated focus day deep dive into emerging discovery technologies alongside two days of cutting-edge GPCR science.
  • Preview exclusive sessions from Eli Lilly, Pfizer, Roche, Recursion Pharmaceuticals, Alphamol, and University of Miami.
  • Discover how the industry is tackling GPCR discovery's biggest challenges, from target validation and signaling biology to AI accountability and biased agonism.
  • See who you'll be networking with, including scientific decision-makers from leading pharma, biotech, and academic organizations.
  • Identify the sessions, speakers, and networking opportunities most relevant to your programs before you attend.
Brochure Cover

What To Expect

80+

GPCR Specialists

56%

Director-Level & Above Attendees

22+

Industry & Academic Speakers

15+

Data-Driven Case Studies

7+

Hours

Dedicated Networking

4+

Therapeutic Areas Covered

Official Partners

Brochure Cover
Quick Download
explore the agenda
Explore the Agenda

Discover the latest advances in AI-enabled discovery, target validation, signaling biology, and emerging GPCR therapeutics across three days of scientific discussion.  

Join Biopharma Experts
Partner With Us

Showcase your expertise to a highly targeted audience of scientists and decision-makers actively seeking technologies, services, and partners to accelerate GPCR discovery.

Partner With Us
Join the GPCR Community

Connect with leading pharma, biotech, and academic experts tackling the biggest challenges and opportunities shaping the future of GPCR drug discovery.